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C
ells with a defective spindle get delayed—stuck in a mitotic 
checkpoint—but eventually escape mitosis. In vertebrate 
cells, say Daniela Brito and Conly Rieder (Wadsworth 
Center, New York State Department of Health, Albany, NY), that 
escape is a gradual limp rather than a sudden exit.
The temporary stalling of the cell cycle in a checkpoint gives the 
cell time to repair damage before continuing. Ted Weinert and Lee 
Hartwell gave this phenomenon its name, but “they never viewed a 
checkpoint as leading to a permanent arrest,” says Rieder.
Indeed, even in response to a problem that cannot be fi  xed, 
such as high levels of the anti-microtubule drug nocodazole, 
many cells do leak through the mitotic arrest. In yeast and 
perhaps fl  ies, the escape occurs via phosphorylation of Cdk1 or 
induction of a Cdk1 inhibitor. This adaptation pathway turns off 
the Cdk1/cyclin B complex, whose activity defi  nes mitosis.
A similar abrupt change was expected in vertebrate cells, 
via Cdk1 phosphorylation, induction of a Cdk1 inhibitor, 
or rapid degradation of cyclin B. “But it turns out it doesn’t 
do any of these,” says Rieder. Instead, “human cells slowly 
degrade cyclin B over the course of time.”
This slow, proteasome-dependent degradation of cyclin 
B was required for nocodazole-treated cells to escape from 
mitosis. The spindle assembly checkpoint remained intact and 
active throughout. Thus Brito and Rieder believe that vertebrate 
cells do not turn on a specifi  c adaptation pathway. Instead there 
is a constant low level of cyclin B degradation that eventually 
reduces cyclin B levels below that needed to maintain a mitotic 
state. In plants the resultant exit may allow a change in ploidy, 
although its utility in mammals is less clear.
Reference: Brito, D.A., and C.L. Rieder. 2006. Curr. Biol. 16:1194–1200.
A 
minor change during evolution 
converted the relatively benign 
monkey SIV viruses into deadly 
HIV-1, according to Michael Schindler, 
Frank Kirchhoff (University of Ulm, Ger-
many), and colleagues. They report that 
HIV-1, unlike most SIV strains, has lost the 
ability to protect its T cell hosts, and thus 
its human host, from death.
The critical difference is in a virus 
protein called Nef, which increases virus 
infectivity and replication. But even more 
important than what HIV-1 Nef does may 
be what it does not do.
The German group tested 30 differ-
ent nef alleles in an HIV-1 vector. Most SIV 
Nef proteins down-regulated expression of 
the T cell receptor protein CD3 and thus 
blocked activation of infected T cells. Nef 
from HIV-1 and some closely related SIV 
relatives had neither of these effects.
The T cell activation matters be-
cause of activation-induced cell death 
(AICD). A normal immune reaction starts 
with T cell proliferation. Once an invader 
is cleared, the reaction is self-limited by 
AICD—the suicide of most of the recently 
proliferating T cells. During HIV-1 infec-
tion, however, the virus is not cleared and 
still remains visible to the immune system. 
Repeated cycles of activation lead to ex-
cessive proliferation and excessive AICD. 
The vast turnover of T cells eventually ex-
hausts the immune system.
This AICD was high for HIV-1 and 
the close SIV relatives. But for SIV strains 
that down-regulated CD3, there was no 
activation and thus little cell death. This 
presumably provides a longer-lived cell 
within which SIV takes shelter.
Kirchhoff plans two further tests of the 
hypothesis. SIV engineered to express Nef 
that doesn’t down-regulate CD3 should be 
more pathogenic in monkeys. And less 
pathogenic HIV-2 strains may express Nef 
proteins that down-regulate CD3 less.
A more long-term goal will be to re-
duce AICD, probably by reducing the acti-
vation step. This has been tried in patients 
with full-blown AIDS, “but this is too late,” 
says Kirchhoff. “You need to start this early 
when the immune system is still functional.” 
Kirchhoff conﬁ  rms that using immune sup-
pression to ﬁ  ght an immunosuppresive dis-
ease will be difﬁ  cult: “It won’t be easy to 
ﬁ   nd the right balance. The [simian] virus 
can; the question is whether humans can 
mimic this situation.”
Reference: Schindler, M., et al. 2006. 
Cell. 125:1055–1067.
Less deadly ancestors of HIV-1 down-regulate 
CD3 so their host cells are spared.
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Even when mitotic cells lack a spindle, cyclin (bottom panels) slowly 
fades away.
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How HIV-1 lost control
Slow escape from mitosis